National Registry of IgG4-RD in China

NCT03023371 · tracked via the Priya Life Science China tracker

Sponsor

Peking Union Medical College Hospital

Phase

Observational

Started

2016-12

Last updated

2017-01-24

Condition(s) studied

IgG4-Related Disease

Study summary

The aim of this study is to establish a nation-wide cohort study of IgG4-related disease (IgG4-RD) in China.

Methods: All the patients fulfilling diagnostic criteria of IgG4-RD (2011) would be enrolled from multi-centers around China. A online database system has been established.

Endpoints: The primary endpoint is to investigate the clinical manifestations of Chinese IgG4-RD patients; the secondary endpoints including the demographic features,laboratory characteristics, immunological tests, imaging and pathological features, in addition, the treatment and prognosis of the disease.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Conforming to the diagnostic criteria of IgG4-RD (2011); Exclusion Criteria: * Excluding other mimicing IgG4-RD, including tumors, vasculitis and sarcoidosis.

Primary outcome measure(s)

Organ involvements of Chinese IgG4-RD patients — 5 years
To calculate the percentage of organ involvements in at least 900 patients.

Trial sites (1)

Facility	City	Region	Status
Peking Union Medical College Hospital	Beijing	Beijing Municipality	Recruiting

More Peking Union Medical College Hospital trials in China

68Ga-NY104 PET/CT Guided Radiation Therapy in CcRCC. Recruiting

A Prospective Cohort Study of Myasthenia Gravis in China Recruiting

68Ga-NYM207 PET/CT Imaging in Hepatocellular Carcinoma Starting soon

Polymeric Micellar Paclitaxel-Based Combination Therapy for Advanced Biliary Tract Cancer Active, not recruiting

Moderately Hypofractionated Adaptive Radiotherapy for Cervical Cancer Active, not recruiting

Other trials for the same condition

A Prospective Cohort Study of IgG4RD in China Recruiting

Safety and Efficacy of PRG-1801 for Refractory Lupus Nephritis and IgG4-Related Disease Recruiting

Safety and Efficacy of PRG-2311 for Refractory Lupus Nephritis and IgG4-Related Disease Recruiting

Short-term Glucocorticoid Combined with MMF for IgG4-RD Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03023371 on ClinicalTrials.gov ↗ ← All trials in China